SGLT1 inhibition in cystic fibrosis: From preclinical evidence to clinical potential
- DOI
- 10.1016/j.omta.2026.201868
- Published
- 2026-12
- Container
- Molecular Therapy Advances
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.omta.2026.201868,
title = {SGLT1 inhibition in cystic fibrosis: From preclinical evidence to clinical potential},
author = {Xiubin Liang and Yang Liu and Shijing Jia and Kezhong Zhang and Jie Xu},
year = {2026},
journal = {Molecular Therapy Advances},
doi = {10.1016/j.omta.2026.201868},
url = {https://doi.org/10.1016/j.omta.2026.201868}
}RIS
TY - JOUR TI - SGLT1 inhibition in cystic fibrosis: From preclinical evidence to clinical potential AU - Xiubin Liang AU - Yang Liu AU - Shijing Jia AU - Kezhong Zhang AU - Jie Xu PY - 2026 JO - Molecular Therapy Advances DO - 10.1016/j.omta.2026.201868 UR - https://doi.org/10.1016/j.omta.2026.201868 ER -
APA
Liang, X., Liu, Y., Jia, S., Zhang, K., & Xu, J. (2026). SGLT1 inhibition in cystic fibrosis: From preclinical evidence to clinical potential. Molecular Therapy Advances. https://doi.org/10.1016/j.omta.2026.201868
Source records
- crossref · retrieved 2026-11-09T22:01:53.662Z